Septerna Inc
(SEPN - NASDAQ)
38,09 USD
📋 Profilo Aziendale

Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

|